150 related articles for article (PubMed ID: 15528296)
1. Characterization of novel monoclonal antibodies for prostate-specific antigen (PSA) with potency to recognize PSA bound to alpha 2-macroglobulin.
Baumgart Y; Otto A; Schäfer A; Usbeck E; Cott C; Schott A; Tornack M; Wenzel A; Mossie A; Birkenmeier G
Clin Chem; 2005 Jan; 51(1):84-92. PubMed ID: 15528296
[TBL] [Abstract][Full Text] [Related]
2. Anti-free prostate-specific antigen monoclonal antibody epitopes defined by mimotopes and molecular modeling.
Michel S; Deléage G; Charrier JP; Passagot J; Battail-Poirot N; Sibai G; Jolivet M; Jolivet-Reynaud C
Clin Chem; 1999 May; 45(5):638-50. PubMed ID: 10222350
[TBL] [Abstract][Full Text] [Related]
3. Analysis of prostate specific antigen and alpha1-antichymotrypsin interaction using antipeptide monoclonal antibodies.
Michel S; Charrier JP; Deleage G; Battail-Poirot N; Jolivet M; Jolivet-Reynaud C
J Urol; 2001 Jan; 165(1):301-6. PubMed ID: 11125429
[TBL] [Abstract][Full Text] [Related]
4. Characterization of 10 new monoclonal antibodies against prostate-specific antigen by analysis of affinity, specificity and function in sandwich assays.
Corey E; Wegner SK; Stray JE; Corey MJ; Arfman EW; Lange PH; Vessella RL
Int J Cancer; 1997 Jun; 71(6):1019-28. PubMed ID: 9185706
[TBL] [Abstract][Full Text] [Related]
5. Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA.
Nilsson O; Peter A; Andersson I; Nilsson K; Grundström B; Karlsson B
Br J Cancer; 1997; 75(6):789-97. PubMed ID: 9062397
[TBL] [Abstract][Full Text] [Related]
6. Epitope mapping of antibodies against prostate-specific antigen with use of peptide libraries.
Leinonen J; Wu P; Stenman UH
Clin Chem; 2002 Dec; 48(12):2208-16. PubMed ID: 12446478
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen forms complexes with human alpha 2-macroglobulin and binds to the alpha 2-macroglobulin receptor/LDL receptor-related protein.
Otto A; Bär J; Birkenmeier G
J Urol; 1998 Jan; 159(1):297-303. PubMed ID: 9400498
[TBL] [Abstract][Full Text] [Related]
8. Characterization of monoclonal antibodies against prostate specific antigen produced by genetic immunization.
Leinonen J; Niemelä P; Lövgren J; Bocchi L; Pettersson K; Nevanlinna H; Stenman UH
J Immunol Methods; 2004 Jun; 289(1-2):157-67. PubMed ID: 15251421
[TBL] [Abstract][Full Text] [Related]
9. Generation of PSA-ACT-specific monoclonal antibodies and their application in a sandwich immunoassay.
Wang TJ; Linton HJ; Payne J; Rittenhouse HG; Chan DW; Partin AW; Wolfert RL; Kuus-Reichel K
Hybridoma; 1999 Dec; 18(6):535-41. PubMed ID: 10626683
[TBL] [Abstract][Full Text] [Related]
10. Epitope mapping of prostate-specific antigen with monoclonal antibodies.
Jette DC; Kreutz FT; Malcolm BA; Wishart DS; Noujaim AA; Suresh MR
Clin Chem; 1996 Dec; 42(12):1961-9. PubMed ID: 8969633
[TBL] [Abstract][Full Text] [Related]
11. Three immunoassays based on monoclonal antibodies specific for prostate specific antigen (PSA), alpha-1-antichymotrypsin (ACT), and the PSA-ACT complex.
Wan XS; Xu YA; Ware JH; Kennedy AR
Prostate; 2003 Jul; 56(2):131-41. PubMed ID: 12746838
[TBL] [Abstract][Full Text] [Related]
12. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity.
Finlay JA; Evans CL; Day JR; Payne JK; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Wolfert RL; Rittenhouse HG
Urology; 1998 May; 51(5):804-9. PubMed ID: 9610595
[TBL] [Abstract][Full Text] [Related]
13. Characterization of prostate-specific antigen binding peptides selected by phage display technology.
Ferrieu-Weisbuch C; Michel S; Collomb-Clerc E; Pothion C; Deléage G; Jolivet-Reynaud C
J Mol Recognit; 2006; 19(1):10-20. PubMed ID: 16312021
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen: characterization of epitopes by synthetic peptide mapping and inhibition studies.
Corey E; Wegner SK; Corey MJ; Vessella RL
Clin Chem; 1997 Apr; 43(4):575-84. PubMed ID: 9105257
[TBL] [Abstract][Full Text] [Related]
15. Characterization of epitope structure for 53 monoclonal antibodies against prostate-specific antigen.
Becker C; Wigheden I; Lilja H
Tumour Biol; 1999; 20 Suppl 1():13-7. PubMed ID: 10628403
[TBL] [Abstract][Full Text] [Related]
16. Addition of purified prostate specific antigen to serum from female subjects: studies on the relative inhibition by alpha 2-macroglobulin and alpha 1-antichymotrypsin.
Chen Z; Komatsu K; Prestigiacomo A; Stamey TA
J Urol; 1996 Oct; 156(4):1357-63. PubMed ID: 8808871
[TBL] [Abstract][Full Text] [Related]
17. Characterization of antibodies to prostate-specific antigen.
Nilsson O; Andersson I; Peter A; Karlsson B
Tumour Biol; 1999; 20 Suppl 1():43-51. PubMed ID: 10628409
[TBL] [Abstract][Full Text] [Related]
18. Production and characterization of novel anti-prostate-specific antigen (PSA) monoclonal antibodies that do not detect internally cleaved Lys145-Lys146 inactive PSA.
Nurmikko P; Väisänen V; Piironen T; Lindgren S; Lilja H; Pettersson K
Clin Chem; 2000 Oct; 46(10):1610-8. PubMed ID: 11017939
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies 2F5 and 4G10 against prostate specific antigen (PSA) complexed to alpha1-antichymotrypsin.
Chen Z; Chen H; Stamey TA
J Urol; 1998 Sep; 160(3 Pt 1):870-5. PubMed ID: 9720579
[TBL] [Abstract][Full Text] [Related]
20. ELISA for a complexed antigen with a monoclonal antibody blocking reaction with the free antigen-assay-specific for complexed prostate-specific antigen.
Matsumoto K; Konishi N; Samori T; Kimura E; Doi M; Kato S; Yuki Y
J Immunol Methods; 2000 Feb; 234(1-2):99-106. PubMed ID: 10669774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
